Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-16-017150
Filing Date
2016-09-29
Accepted
2016-09-29 17:05:27
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT f424b5092916_actinium.htm 424B5 972522
2 GRAPHIC image_001.jpg GRAPHIC 8308
3 GRAPHIC atnmlogo.jpg GRAPHIC 48316
  Complete submission text file 0001213900-16-017150.txt   1051836
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-194768 | Film No.: 161910560
SIC: 2834 Pharmaceutical Preparations